Attached files

file filename
10-Q - FORM 10-Q - GALECTIN THERAPEUTICS INCd402747d10q.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR33.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - GALECTIN THERAPEUTICS INCd402747dex312.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - GALECTIN THERAPEUTICS INCd402747dex321.htm
EX-10.3 - EMPLOYMENT AGREEMENT - GALECTIN THERAPEUTICS INCd402747dex103.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - GALECTIN THERAPEUTICS INCd402747dex311.htm
EXCEL - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR6.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR9.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR2.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR5.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR3.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR1.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR7.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR8.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR4.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR21.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR14.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR17.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR23.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR32.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR26.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR18.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR30.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR10.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR24.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR20.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR15.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR28.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR13.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR16.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR19.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR27.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR12.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR11.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR25.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR31.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR22.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - GALECTIN THERAPEUTICS INCd402747dex322.htm
v2.4.0.6
Common Stock Warrants - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended 147 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended
May 31, 2010
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Mar. 28, 2012
Mar. 22, 2012
Aug. 31, 2010
Apr. 30, 2009
Sep. 30, 2011
Warrant two
Mar. 28, 2012
Warrant two
Sep. 30, 2011
Warrant two
Minimum
Sep. 30, 2011
Warrant two
Maximum
Sep. 30, 2012
Warrant one
Sep. 30, 2011
Warrant one
Sep. 30, 2012
Warrant one
Sep. 30, 2011
Warrant one
Mar. 28, 2012
Warrant one
Mar. 07, 2011
Warrant three
Aug. 31, 2010
Warrant three
Sep. 30, 2011
Warrant three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Warrants to purchase shares of common stock 12,000           1,333,361   100,000 33,333   46,378             1,333,361      
Exercise price of warrant 15.00             5.63 4.26 3.00   5.63                    
Reversal of previously recognized expense                             $ 10,000 $ 36,000 $ 98,000 $ 16,000        
Vested warrant 7,500                                       25,000  
Forfeited warrant 4,500     616,726                                    
Expected life       5 years 4 months 24 days 5 years 1 month 6 days 5 years 1 month 6 days             2 years 11 months 27 days 3 years 3 months 26 days           4 years 3 months 11 days    
Volatility rate, minimum                     128.00%                      
Volatility rate, maximum                     130.00%                      
Risk free interest, minimum                     0.79%                      
Risk free interest, Maximum                     1.29%                      
Expected dividend rate       0.00% 0.00% 0.00%         0.00%                 0.00%    
Stock-based compensation expense   $ 819,000 $ 649,000 $ 2,170,000 $ 2,688,000 $ 11,752,000         $ 12,000                     $ 340,000
Warrant expected to vest in one year                                         25,000  
Warrant that will vest upon the achievement of certain milestones                                         50,000  
Volatility rate       117.00% 121.00% 119.00%                           135.00%    
Risk free interest       0.84% 1.91% 1.87%                           1.705%